Q4 impact: Global brokerages cut target price for Cadila Healthcare

-

Citigroup maintained its sell rating on Cadila Healthcare while Credit Suisse maintained its neutral rating on Cadila Healthcare post Q4 results.





Global brokerage firms Citigroup, Macquarie and Credit Suisse maintained their rating but slashed their target price on Cadila Healthcare post Q4 results.

Cadila Healthcare's March quarter consolidated profit fell 22.1 percent year-on-year to Rs 460 crore hit by weak operating income.

Consolidated revenue during the quarter grew 15.3 percent to Rs 3,771.2 crore compared to the same period last year as the US formulations business registered a 9.3 percent growth and Emerging Markets formulations business grew 7.1 percent YoY.


India formulations business grew 2.1 percent YoY but EU formulations business fell 11.2 percent while API business showed a 6.7 percent growth YoY.

Citigroup maintained its sell rating on Cadila Healthcare but slashed its target price to Rs 255 from Rs 330 earlier.

The result was largely in-line with estimates but the guidance was underwhelming, Citi said. The global investment bank expects a sluggish phase in earnings, which is now playing out. Moraiya observation has clouded the outlook on its US pipeline, and the Heinz business acquisition also appears ROCE dilutive.

Another global investment bank, Macquarie maintained its outperform rating but slashed its target to Rs 340 from Rs 372 earlier.

The global investment bank has also lowered FY20/21 EPS estimates by 13/12 percent, to build in OAI status or Official Action Indicated for Moraiya.

At 14x FY21e PER, the risk-to-reward ratio is favourable for investors and going forward new launches are likely to offset Moraiya hit.

Credit Suisse maintained its neutral rating on Cadila Healthcare slashed its target to Rs 283 from Rs 330 earlier.

The company guided for a weak outlook with earnings flat for the next four years. In the near-term, Moraiya facility flag classification is the key event to watch out for, Credit Suisse said.

The global investment bank expects the company's US generic sales to grow by a low single digit. It has slashed FY19-21 EPS estimates by 4-5 percent.


Best Share Market News, Click Here To Get More News - Stock Market tips, for 2 Days Free Trial give a missed call @9644405057 and Get Share Market Services.

Comments

Post a Comment

Popular posts from this blog

Daily equity Market By Ripplesadvisory Report 16-Aug-2016

-
MARKET WRAP UP The Sensex and Nifty jumped over one per cent on Friday and were headed for their second session of gains, led by energy stocks, including Reliance Industries Ltd, as oil prices extended their rally. Domestic sentiment was also buoyed on continued buying by investors ahead of IIP and inflation data scheduled to be released later in the day. US stocks closed at record highs on Thursday as surging oil prices and strong earnings buoyed investor sentiment, giving a boost to Asian markets. Dealers said widening of positions by participants ahead of key economic data —— industrial production (IIP) for June and consumer price index (CPI) for July —— to be released after market closing today also added to the upbeat investor sentiment. At 3.05 pm, the Sensex was up 315.38 points or 1.13 per cent at 28,174.98 while the NSE Nifty was up 85.7 points or 1.00 per cent at 8,677.85. Sentiment also got a boost as foreign investors continued to buy Indian shares for a...
Read more

Axis Bank agrees to buy to payments wallet provider FreeCharge for $60 million

-
Image
Axis Bank Ltd, India's seventh-biggest lender by assets, said on Thursday it had agreed to buy mobile payments wallet provider FreeCharge from e-commerce company Snapdeal for 3.85 billion rupees ($60.04 million). Most valuable Financial Advisory with the name of accurate tips provider here invites you to trade in a financial market with risk-free work click here for more >>  http://www.ripplesadvisory.com/free-trial.php "Digital payments in India are surging. Government policies are driving a less-cash economy," Axis Bank finance chief Jairam Sridharan told a news conference after announcing the deal.
Read more

Axis Bank Declines after Reporting Tepid Q4 Results

-
Image
For more Live premium stock future Visit Us:- http://ripplesadvisory.com/premium-stock-future-.php or Get Free Trials Just Call @96-44-40-50-56. Axis Bank declined 1.72% to Rs 508.40 at 9:40 IST on BSE after net profit dropped 43.13% to Rs 1225.10 crore on 4.33% rise in total income to Rs 14181.31 crore in Q4 March 2017 over Q4 March 2016. The result was announced after market hours yesterday, 26 April 2017. Meanwhile, the S&P BSE Sensex was down 29.63 points or 0.1% at 30,103.72. On the BSE, 5.08 lakh shares were traded on the counter so far as against the average daily volumes of 9.17 lakh shares in the past one quarter. The stock had hit a high of Rs 525 and a low of Rs 503.60 so far during the day. The stock had hit a 52-week high of Rs 638 on 7 September 2016 and a 52-week low of Rs 424.60 on 10 January 2017. The stock had outperformed the market over the past one month till 26 April 2017, rising 5.74% compared with the Sensex's 2.42% rise. The sc...
Read more